Literature DB >> 14724177

NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK.

Jennifer Y Zhang1, Cheryl L Green, Shiying Tao, Paul A Khavari.   

Abstract

NF-kappaB inhibition promotes epidermal tumorigenesis; however, whether this reflects an underlying role in homeostasis or a special case confined to neoplasia is unknown. Embryonic lethality of mice lacking NF-kappaB RelA has hindered efforts to address this. We therefore generated developmentally mature RelA(-/-) skin. RelA(-/-) epidermis displays hyperplasia without abnormal differentiation, inflammation, or apoptosis. Hyperproliferation is TNFR1-dependent because Tnfr1 deletion normalized cell division. TNFR1-dependent JNK activation occurred in RelA(-/-) epidermis, and JNK inhibition abolished hyperproliferation due to RelA deficiency. Thus, RelA antagonizes TNFR1-JNK proliferative signals in epidermis and plays a nonredundant role in restraining epidermal growth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14724177      PMCID: PMC314269          DOI: 10.1101/gad.1160904

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  37 in total

Review 1.  Missing pieces in the NF-kappaB puzzle.

Authors:  Sankar Ghosh; Michael Karin
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  NF-kappaB signaling. Many roads lead to madrid.

Authors:  Vishva Dixit; Tak W Mak
Journal:  Cell       Date:  2002-11-27       Impact factor: 41.582

3.  The p65/RelA subunit of NF-kappaB suppresses the sustained, antiapoptotic activity of Jun kinase induced by tumor necrosis factor.

Authors:  Julie Y Reuther-Madrid; David Kashatus; Shaoqiong Chen; Xiong Li; John Westwick; Roger J Davis; H Shelton Earp; Cun-Yu Wang; Albert S Baldwin
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

4.  SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase.

Authors:  B L Bennett; D T Sasaki; B W Murray; E C O'Leary; S T Sakata; W Xu; J C Leisten; A Motiwala; S Pierce; Y Satoh; S S Bhagwat; A M Manning; D W Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

5.  Inhibition of JNK activation through NF-kappaB target genes.

Authors:  G Tang; Y Minemoto; B Dibling; N H Purcell; Z Li; M Karin; A Lin
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

Review 6.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

7.  The specificities of protein kinase inhibitors: an update.

Authors:  Jenny Bain; Hilary McLauchlan; Matthew Elliott; Philip Cohen
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

8.  NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.

Authors:  Maya Dajee; Mirella Lazarov; Jennifer Y Zhang; Ti Cai; Cheryl L Green; Alan J Russell; M Peter Marinkovich; Shiying Tao; Qun Lin; Yoshiaki Kubo; Paul A Khavari
Journal:  Nature       Date:  2003-02-06       Impact factor: 49.962

9.  IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program.

Authors:  Xiang Li; Paul E Massa; Adedayo Hanidu; Gregory W Peet; Patrick Aro; Ann Savitt; Sheenah Mische; Jun Li; Kenneth B Marcu
Journal:  J Biol Chem       Date:  2002-09-06       Impact factor: 5.157

10.  TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2.

Authors:  Manolis Pasparakis; Gilles Courtois; Martin Hafner; Marc Schmidt-Supprian; Arianna Nenci; Atiye Toksoy; Monika Krampert; Matthias Goebeler; Reinhard Gillitzer; Alain Israel; Thomas Krieg; Klaus Rajewsky; Ingo Haase
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

View more
  52 in total

Review 1.  Transcriptional control of epidermal specification and differentiation.

Authors:  Xing Dai; Julia A Segre
Journal:  Curr Opin Genet Dev       Date:  2004-10       Impact factor: 5.578

Review 2.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  Human papillomavirus type 16 E6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization.

Authors:  Erik R Vandermark; Krysta A Deluca; Courtney R Gardner; Daniel F Marker; Cynthia N Schreiner; David A Strickland; Katelynn M Wilton; Sumona Mondal; Craig D Woodworth
Journal:  Virology       Date:  2012-01-28       Impact factor: 3.616

4.  Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation.

Authors:  Bach-Cuc Nguyen; Karine Lefort; Anna Mandinova; Dario Antonini; Vikram Devgan; Giusy Della Gatta; Maranke I Koster; Zhuo Zhang; Jian Wang; Alice Tommasi di Vignano; Jan Kitajewski; Giovanna Chiorino; Dennis R Roop; Caterina Missero; G Paolo Dotto
Journal:  Genes Dev       Date:  2006-04-15       Impact factor: 11.361

Review 5.  Multiple functions of the integrin alpha6beta4 in epidermal homeostasis and tumorigenesis.

Authors:  Kevin Wilhelmsen; Sandy H M Litjens; Arnoud Sonnenberg
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 6.  Scratching the surface of skin development.

Authors:  Elaine Fuchs
Journal:  Nature       Date:  2007-02-22       Impact factor: 49.962

7.  Tuning of protein kinase circuitry by p38α is vital for epithelial tissue homeostasis.

Authors:  Celia Caballero-Franco; Min-Kyung Choo; Yasuyo Sano; Patcharee Ritprajak; Hiroaki Sakurai; Kinya Otsu; Atsushi Mizoguchi; Jin Mo Park
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

8.  Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.

Authors:  Matthew L Fisher; Jeffrey W Keillor; Wen Xu; Richard L Eckert; Candace Kerr
Journal:  Mol Cancer Res       Date:  2015-05-01       Impact factor: 5.852

Review 9.  IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy.

Authors:  Jun-Li Luo; Hideaki Kamata; Michael Karin
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

10.  p65/RelA modulates BECN1 transcription and autophagy.

Authors:  Tamara Copetti; Cosetta Bertoli; Emiliano Dalla; Francesca Demarchi; Claudio Schneider
Journal:  Mol Cell Biol       Date:  2009-03-16       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.